Tech Reporter Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Reporter Virgin Islands.

Press releases published on August 13, 2026

Aug. 13, 2026

Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire

Aug. 13, 2026

ROC Reports Second-Quarter 2026 Revenue Doubled Sequentially; Steady Government Contract Activity Delivers 41% YoY R&D Revenue Growth

Indeterminate GlobeNewswire

Aug. 13, 2026

Merlin, Inc. Reports Second Quarter 2026 Results

Indeterminate GlobeNewswire

Aug. 13, 2026

Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 13, 2026

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026

Indeterminate GlobeNewswire

Aug. 13, 2026

Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire

Aug. 13, 2026

Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 13, 2026

XBP Global Holdings, Inc. Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 13, 2026

Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates

Indeterminate GlobeNewswire

Aug. 13, 2026

Alumis Reports Second Quarter 2026 Financial Results and Highlights Recent Achievements

Indeterminate GlobeNewswire

Aug. 13, 2026

ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 13, 2026

Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

Aug. 13, 2026

Aktis Oncology Reports Financial Results and Business Highlights for the Second Quarter 2026

Indeterminate GlobeNewswire

Aug. 13, 2026

Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering

Indeterminate GlobeNewswire

Aug. 13, 2026

ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate Highlights

Indeterminate GlobeNewswire

Aug. 13, 2026

Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates

Indeterminate GlobeNewswire

Aug. 13, 2026

Mdxhealth Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 13, 2026

Noldor Appoints Tom Anderson as Head of Sales

Indeterminate GlobeNewswire

Aug. 13, 2026

How to Earn Interest on Business Cash: Balance Cash Explains How Companies Put Idle Operating Cash to Work Without Switching Banks

Indeterminate GlobeNewswire

Aug. 13, 2026

Gene Therapy Remains Top-of-Mind in Hemophilia Despite Recent Market Contraction, as Physicians and Patients Raise the Bar for Success

Indeterminate GlobeNewswire